YM BioSciences increases offering size to approximately US$17.5 million
08. März 2010Press Release Source: YM BioSciences Inc. On Monday March 8, 2010, 8:49 amMISSISSAUGA, ON, March 8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), today announced that the previously announced offering of...
YM BioSciences to raise approximately US$15 million
05. März 2010Press Release Source: YM BioSciences Inc. On Friday March 5, 2010, 9:19 amMISSISSAUGA, ON, March 5 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), today announced that it is raising approximately US$15...
YM sees nimotuzumab license unaffected by civil claim against licensor
02. März 2010Press Release Source: YM BioSciences Inc. On Tuesday March 2, 2010, 10:15 amMISSISSAUGA, ON, March 2 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announces that it filed a Form 6K describing that certain...
YM BioSciences presents CYT387 and CYT997 data at international cancer conference
11. Februar 2010Press Release Source: YM BioSciences Inc. On Thursday February 11, 2010, 7:30 am
YM BIOSCIENCES GRANTED TWO US PATENTS FOR AEROLEF®
10. Februar 2010Additional AeroLEF patents granted in Europe, China and other territories
